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Abstract
Background: There has been a worldwide increase in allergy and asthma over the last few
decades, particularly in industrially developed nations. This resulted in a renewed interest to
understand the pathogenesis of allergy in recent years. The progress made in the pathogenesis of
allergic disease has led to the exploration of novel alternative therapies, which include herbal
medicines as well. Curcumin, present in turmeric, a frequently used spice in Asia has been shown
to have anti-allergic and inflammatory potential.
Methods: We used a murine model of latex allergy to investigate the role of curcumin as an
immunomodulator. BALB/c mice were exposed to latex allergens and developed latex allergy with
a Th2 type of immune response. These animals were treated with curcumin and the immunological
and inflammatory responses were evaluated.
Results: Animals exposed to latex showed enhanced serum IgE, latex specific IgG1, IL-4, IL-5, IL-
13, eosinophils and inflammation in the lungs. Intragastric treatment of latex-sensitized mice with
curcumin demonstrated a diminished Th2 response with a concurrent reduction in lung
inflammation. Eosinophilia in curcumin-treated mice was markedly reduced, co-stimulatory
molecule expression (CD80, CD86, and OX40L) on antigen-presenting cells was decreased, and
expression of MMP-9, OAT, and TSLP genes was also attenuated.
Conclusion: These results suggest that curcumin has potential therapeutic value for controlling
allergic responses resulting from exposure to allergens.
Background
Recent years have witnessed an increased prevalence of
allergy and asthma among people in developed countries
[1-4]. Although not of the same magnitude, similar
increases in allergic diseases have also been observed in
developing countries [5]. Search for novel treatments have
significantly advanced in recent years. This increased
attention has led to the exploration of alternative medi-
cines with particular interest in plant products that have
been in use for many years in the old world countries.
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Reviews published in recent years suggest that some of
these folklore medicines have significant effect in reduc-
ing the severity of respiratory disease symptoms and
improving patient's quality of life [6,7].
Alternative medicines, particularly plant extracts have
shown acceptance by patients and physicians alike [6-8].
However, no detailed scientific studies have been con-
ducted to further the understanding of the anti-allergic
mechanisms associated with these products. In spite of
the lack of information, a substantial interest has been
shown to alternative and supplementary medicines. Cur-
rently, closer to 2,000 herbal products are available for the
treatment of various ailments and the list is steadily grow-
ing [6,7].
A number of herbs and herbal products have been used in
the treatment of allergy and asthma in ancient traditional
Chinese medicine, Indian Ayurvedic medicine, and Japa-
nese Kampo medicine [8-14]. However, few scientific
studies have been carried out to ascertain their action and
effectiveness [15,16]. In recent years, turmeric, a spice
used in Asian countries, has attracted the attention of
researchers due to its reported effectiveness in inflamma-
tory and other disorders [17,18]. The effectiveness of cur-
cumin, the active component of turmeric, has been
evaluated in various diseases, but not for asthma and
allergy, in spite of the fact that it has been used in the treat-
ment of asthma and allergy for many centuries [17-19].
Here, we report our findings on the immunomodulatory
role of curcumin in a mouse model of latex allergy. The
results indicate that curcumin downregulated Th2
responses and reduced lung inflammation in latex sensi-
tized mice, suggesting a possible role for curcumin in con-
trolling allergic responses.
Materials and methods
Sensitization of Mice with Latex Allergens
Latex allergy in BALB/c mice was induced according to a
protocol described previously [20-22]. In brief, 8–10 week
old BALB/c mice were divided into three groups. The first
group (Group 1) was challenged with latex allergens, the
second group (Group 2) was challenged with latex and
treated with curcumin (Sigma Chemicals), and the third
group (Group 3) consisted of controls treated with curcu-
min only. 100 μg of a Malaysian non-ammoniated
(MNA) latex extract, isolated from sap collected from the
rubber plant Hevea brasiliensis, was injected intraperito-
neally into the mice, once a week for two weeks. Remain-
ing challenges were done intranasally twice a week for
four weeks (50 μg of latex in 30 μl of PBS per challenge)
(Groups 1 and 2). Intranasal inoculations with latex anti-
gen and intragastric administration of curcumin (250 μg
in 250 μl PBS) (Group 2) were carried out after anesthe-
tizing the mice with xylazine. Control animals (Group 3)
received PBS intranasally and curcumin intragastrically.
The levels of total serum IgE and latex specific IgG1 were
measured by ELISA as described previously [22]. When a
significant antibody response was detected, the animals
were challenged with a final dose of latex allergens, and
euthanized 48 hours later. Blood, lung tissue, and spleens
were collected and evaluated as described below. The ani-
mal studies were approved by the Veterans Affairs Animal
Care Committee.
Total Serum IgE
Total serum IgE levels were determined in all mice before
sensitization and after euthanization as previously
reported [22,23]. Serum IgE levels was expressed as ng/ml
after comparing the optical density (O.D. at 480nm) values
to mouse IgE standards.
Latex Specific IgG1 and IgG2a in the Sera of Mice
Levels of latex antigen-specific IgG1 and IgG2a in collected
serum samples were studied by ELISA as previously
described [22]. In brief, micro titer plate wells (Immulon
II, Fisher Scientific, Itasca, IL) were coated with 5 μg/ml of
latex proteins in PBS (pH 7.4). The plates were incubated
at room temperature for 3 hours, followed by overnight
incubation at 4°C. The plates were then washed with PBS
and after blocking the wells with 0.5% Bovine serum albu-
min in PBS, 100 μl of serum diluted in PBS containing
0.05% Tween 20 (PBS-T) was added to the wells, and the
plates incubated at room temperature for three hours. The
wells were washed with PBS-T and isotype specific bioti-
nylated anti-mouse antibody was added for an additional
hour. The plates were washed again and streptavidin con-
jugated horse radish peroxidase was added to the wells for
one hour. After washing the plates, the substrate was
added and the color developed with O-phenylene
diamine (OPD). The color development was stopped by
adding 2N H2S04, and the optical density (O.D.) read at
490nm using an ELISA reader. The O.D. values of several
serum dilutions were used to calculate log10 titer, and the
different groups were compared.
Eosinophils
Peripheral blood eosinophils were plated on slides
stained with Eosin-Y and enumerated using a hemacy-
tometer [23]. Eosinophil numbers were assessed before
and during sensitization and at the end of the experiment.
Lung Histology
Immediately after sacrifice, the lungs were inflated with
10% neutral buffered formalin to prevent atelectasis. The
specimens then were fixed in formalin and processed. Sec-
tions were cut at 5 μm thickness and stained with hema-
toxylin-eosin and PAS. Lung inflammation was scored
with special reference to the infiltrating cell types and the
severity of lesions as described previously [22-24].Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Immunohistochemistry
Lung sections were examined for cells producing IFN-γ, IL-
4, IL-5, IL-10, and IL-13 by immunohistochemistry as pre-
viously described [25]. Lungs were frozen in liquid nitro-
gen and frozen sections from different groups of mice
were fixed in 4% paraformaldehyde. The sections were
incubated in 0.3% H2O2 in PBS for 15 minutes. After
washing three times with PBS for five minutes each, the
sections were blocked with PBS containing 5% bovine
serum albumin (BSA) for three hours. The sections were
then incubated for two hours at room temperature with
1:20 diluted biotinylated anticytokine antibodies (Pierce,
R&D) in PBS containing 3% BSA. The slides were then
incubated for 30 minutes at room temperature with
streptavidin peroxidase (1:50 diluted). The color was
developed with 3,3-diaminobenzidine tetra chloride
(DAB) (Sigma). Numbers of cytokine positive cells were
determined by counting five different microscopic fields.
Spleen Cells
Spleens were processed into single cell suspensions and
antigen dependent proliferation studied by tritiated thy-
midine uptake [26]. Briefly, spleen cells (1 × 105/well)
were cultured for seven days in 96 well plates in 200 μl of
RPMI 1640 medium supplemented with glutamine,
sodium pyruvate, 10% heat inactivated fetal bovine serum
(FBS), and penicillin and streptomycin (complete RPMI).
Latex antigen (5 μg/ml) or Concanavalin A (5 μg/ml) was
added to experimental wells [27]. One μCi of 3 [H] thymi-
dine was added for the final 18 hours of culture. The
incorporated 3H thymidine was measured by liquid scin-
tillation counting, and the stimulation indices (SI) were
calculated as described before [26].
Cytokine Production by Spleen Cells
Spleen cells (1 × 107) were placed in complete RPMI and
cultured in 24 well plates for 60 hours. Latex antigen (5
μg/ml) was added to experimental wells at the beginning
of culture. After incubation, cell free supernatants were
collected and analyzed for cytokines by ELISA, including
IL-4, IL-5, IL-10, IL-13, and IFN-γ [26].
Flow Cytometric Analysis of Lung Cells
Lungs were removed aseptically and cut into small pieces
of about 2 to 3 mm in size. The pieces were digested enzy-
matically by treating with 120 μg/ml Dispase (Invitrogen)
and Collagenase (Sigma) for one hour at 37°C. After incu-
bation, the tissue was homogenized gently in a tissue
grinder and the cells were collected. These cells were
washed three times, and the lung cells for each group were
pooled (equal numbers from each mouse) and suspended
in complete RPMI. The cells were stained with combina-
tions of FITC and PE conjugated antibodies specific for
CD4, CD8, CD25, CD28, CD80, CD86, CD152, OX40,
B220, or Mac-1 (26). The stained cells were run through a
FACS Calibur flow cytometer (Becton-Dickinson, Moun-
tain View, CA) and analyzed using FlowJo software (Tree
Star, San Carlos, CA).
RNA Isolation
Total RNA was isolated using RNeasy mini kits (Qiagen,
Valencia, CA) [28]. Briefly, lung tissues were homoge-
nized using disposable pestles and tubes (Kontes Glass
Company, Vineland, NJ) in the presence of lysis buffer.
Lysates were transferred to QIAshredder spin columns
(Qiagen), spun for 2 minutes, the eluates collected, and
RNA isolated as per the manufacturer's protocol. The RNA
was quantified by measuring OD (Nanodrop ND-1000,
Wilmington, DE).
One Step RT-PCR
One-step RT-PCR reactions were performed in triplicate
using TaqMan one-step RT PCR (Applied Biosystems,
Branchburg, NJ) [29]. Briefly, the sequence specific FAM-
labeled Taqman primer-probe pairs (Applied Biosystems,
Foster City, CA) and 10 ng total RNA were mixed with
reaction buffer supplied by the manufacturer in a 20 μl
reaction volume. The sequential one-tube reverse tran-
scription and real time PCR were performed in an Opti-
con 2 thermal cycler (MJ Research/Bio Rad Laboratories,
Hercules, CA). The temperature conditions included an
initial 48°C incubation for 30 minutes, followed by
AmpliTaq Gold activation at 95°C for 10 min, 40 cycles
of amplification at 95°C for 30 sec and 60°C for 1 min
cycles. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH; assay id: Mm99999915_g1) was used as an
internal control. Applied Biosystem Taqman gene expres-
sion primer-probe pairs specific to lymphocyte antigen 75
(Ly5, Assay id: Mm00522144_m1), matrix metallopepti-
dase 9 (MMP9; Assay id: Mm00600163_m1), ornithine
amino transferace (OAT; Assay id: Mm00497544_m1)
and thymic stromal lymphopoietin (TSLP; Assay id:
Mm00498739_m1) were used.
Statistical Analysis
Total serum IgE levels, latex specific IgG1  and IgG2a,
peripheral blood eosinophils, cytokine production and
stimulation of spleen cells in response to latex antigens in
vitro were compared among different groups of mice. The
data were analyzed and compared using student 't' test
with unequal variance and the results expressed as means
± SEM. 'P values' < 0.05 were considered significant. The
flow cytometric studies were conducted with pooled lung
cells and the results are presented as such. PCR values
were calculated as the mean results of three separate mice.
Results
Total Serum IgE and Latex Specific IgG
There was a significant increase in total serum IgE levels in
animals exposed to latex antigens as compared to controlsClinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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(Fig. 1A). This increase was arrested in mice challenged
with latex and treated with curcumin. However, the differ-
ence between curcumin treated and untreated mice was
not statistically significant.
Latex specific IgG1, IgG2a, IgG2b, and IgG3 was readily
detected in the serum of latex-sensitized mice (Fig. 1C).
This increase in specific antibody was several fold greater
than the baseline antibody levels detected in unexposed
controls. The control mice treated with curcumin only (no
latex sensitization) showed only baseline values.
Peripheral Blood Eosinophils
The numbers of eosinophils in the peripheral blood of
latex-sensitized mice were markedly elevated as compared
to PBS controls (Fig. 1B). Notably, curcumin treatment
significantly decreased the numbers of eosinophils in
latex sensitized mice (p < 0.05). Control mice treated with
curcumin alone had normal numbers of eosinophils.
Antigen Induced Lymphocyte Stimulation
Latex allergens (MNA) were unable to induce the prolifer-
ation of spleen cells from latex sensitized mice (data not
shown), possibly due to toxicity of the latex extract prepa-
ration [19]. In contrast, the recombinant latex allergen,
Hev b 6 was used to stimulate spleen cells, enhanced pro-
liferation was detected in cells from latex antigen exposed
mice (data not shown). Curcumin treatment of latex sen-
sitized mice only marginally affected Hev b 6 induced
lymphocyte proliferation (data not shown). Concanava-
lin-A induced stimulation of lymphocytes from latex chal-
lenged mice showed reduced proliferation as compared to
controls, and this decreased proliferation was partially
restored in latex challenged mice treated with curcumin
(results not shown).
Cytokine Production by Spleen Cells
Cytokines were not detected in the culture supernatants of
cultured spleen cells from curcumin treated or PBS treated
control mice (Fig. 1D &1E). Spleen cells stimulated with
Hev b 6 also failed to produce detectable levels of
cytokines. Varying levels of cytokines were detected in the
culture supernatants of antigen stimulated cells and from
latex sensitized mice treated with curcumin. Reduced lev-
els of IFN-γ were detected from cells of latex sensitized
mice compared to cells from normal mice, while
increased amounts of IFN-γ were produced from the cells
of mice challenged with latex and treated with curcumin
(Fig. 1D). Although, IL-4 production was only slightly
reduced in culture supernatants from latex sensitized mice
treated with curcumin (Fig. 1E), overall the cytokine pro-
files indicated that curcumin shifted the latex-induced
Th2 response towards a Th1 type of response. No major
differences were detected for IL-5, IL-10, and IL-13 (results
not shown).
Analysis of Lung Tissue
Messenger RNA was isolated from the lung tissue and
studied for Ly75 (CD205), MMP9, OAT and TSLP expres-
sion. The results indicated that there were diverse
responses in the different groups of mice (Fig. 2). Expres-
sion of OAT, MMP9, and Ly75 (CD205) were increased in
latex sensitized mice as compared to untreated PBS con-
trols, while TSLP levels were similar. There was a marked
reduction in the expression of all four genes in latex sensi-
tized mice treated with curcumin.
Flow Cytometric Analysis of Lung Cells
Expression of costimulatory molecules on lung cells from
experimental mice were examined by flow cytometry,
including CD28, OX40, and CTLA-4 on T-cells, and
CD80, CD86, and OX40L on B cells and macrophages. A
representative histogram shown in panel A1 of Figure 3
depicts CD80 expression on lung B cells from the different
treatment groups. Increased percentages of B cells express-
ing CD80 were detected in the lungs of latex-sensitized
mice as compared to PBS controls (Fig. 3A2). Curcumin
treatment reduced the expression of CD80 on lung B cells
of latex-sensitized mice (Fig. 3A1), and the reduced
expression was reflected by decreased percentages of lung
B cells expressing CD80 (Fig. 3A2) and decreased CD80
median fluorescence values (Fig. 3A3). Lung B cells from
mice sensitized with latex and treated with curcumin also
showed reduced CD86 and OX40L expression as com-
pared to lung B cells from latex-sensitized mice (Fig. 3B
and 3C, respectively), and the expression of CD80, CD86,
OX40L on lung macrophages exhibited a similar pattern
(Fig. 3D–F). Finally, percentages of lung CD4+ T cells
expressing OX40 and OX40 median fluorescence values
were decreased in latex-sensitized/curcumin treated mice
as compared to latex-sensitized mice (Fig. 3G). Curcumin
treatment also resulted in slightly reduced percentages of
lung CD4+ T cells expressing CTLA-4 (21.6% vs. 29.3% in
latex-sensitized mice as compared to 7.6% in control
mice), while no differences were observed in regard to
CD28 expression (data not shown).
Lung Histology
Mice sensitized with latex antigen showed significant
interstitial inflammation with peribronchiolar and
perivascular infiltrates (Fig. 4). The inflammatory cells
primarily consisted of small lymphocytes with plasma
cells and epitheloid histiocytes. In PAS stained sections,
increased numbers of bronchial epithelial cells, particu-
larly PAS positive goblet cells were discernable (Fig. 4B, E,
F &4I). Bronchial epithelial cell hyperplasia was predom-
inant in latex challenged mice (Fig. 4C). A marked
increase in eosinophils was evident in latex challenged
mice (Fig. 4C &4D), but was considerably reduced in latex
challenged mice treated with curcumin (Fig. 4G &4H). In
the curcumin treated, latex sensitized mice there was onlyClinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Total serum IgE, peripheral blood eosinophils, latex specific antibodies, and cytokine responses Figure 1
Total serum IgE, peripheral blood eosinophils, latex specific antibodies, and cytokine responses. A. Total serum IgE in nano-
gram per ml in controls (Group1); latex sensitized mice (Group 2); and latex sensitized mice treated with curcumin (Group 3). 
B. Peripheral blood eosinophils in the three groups. C. Serum IgG1,2a,2b, and IgG3 latex specific antibodies. The antibody levels 
were calculated from the O.D. values of at least five two-fold dilutions and log titers calculated using a computerized program. 
D. IFN-γ production (ng/ml) by antigen-stimulated spleens cells as measured by ELISA. E. IL-4 production (Pg/ml) by antigen-
stimulated spleen as measured by ELISA.Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Relative mRNA expression of CD205, MMP-9, OAT, and TSLP in the lungs of control and experimental mice Figure 2
Relative mRNA expression of CD205, MMP-9, OAT, and TSLP in the lungs of control and experimental mice.Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Expression of costimulatory molecules on cells from the lungs of control, latex-sensitized, and latex-sensitized mice treated  with curcumin Figure 3
Expression of costimulatory molecules on cells from the lungs of control, latex-sensitized, and latex-sensitized mice treated 
with curcumin. Lung cells were pooled from mice in each group and analyzed by flow cytometry. Representative histograms 
comparing CD80 expression on B cells from the three groups tested are shown in panel A1. CD80 expression is shown as 
percent positive (% Pos) cells in Panel A2, and as median fluorescence (FL) values in Panel A3. The percentages of positive cells 
and median fluorescence values are shown for CD86 and OX40L on B cells in Panels B and C, respectively. Similarly, CD80, 
CD86, and OX40L expression on lung macrophages is shown for the three groups in Panels D, E, and F. Percentages of CD4+ 
T cells expressing OX40 and the median fluorescence values for OX40 are shown in Panel G.Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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minimal perivascular edema and moderate perivascular
cuffing with infiltration of neutrophils and mononuclear
cells. These mice also had fewer lesions consistently
devoid of eosinophils, although some neutrophils and
mononuclear cells were discernible (Fig. 4G &4H). There
was also less bronchial epithelial hyperplasia and no gob-
let cells (Fig. 4G, H &4I). Control mice treated with PBS
and curcumin showed normal lung pathology (Fig. 4A
&4B).
Immunohistochemistry
Lung tissue sections were stained for IL-4, IL-5, IL-10, IL-
13 and IFN-γ. Cytokine producing cells in the lungs of
PBS-treated control mice could only be detected in low
numbers for IL-10 and IFN-γ (Fig. 5D). There was a
marked increase in lung cells secreting IL-4, IL-5, IL-13,
and IFN-γ in the latex-challenged mice (Fig. 5A, B, C, D).
Curcumin treatment of latex sensitized mice resulted in a
marked decrease in IL-4, IL-5, and IL-13 expressing cells
(Fig. 5A, B &5C).
Discussion
Intranasal challenge with latex allergens induced a strong
IgE and eosinophil response with characteristic inflamma-
tory changes in the lungs of mice as reported previously
[21,22]. Other features of this model included enhanced
IL-4 secretion by antigen stimulated spleen cells and
reduced production of IFN-γ. We also detected slightly
enhanced mRNA levels of Ly75 (CD-205), MMP-9, and
OAT in mice challenged with latex allergens. Immunohis-
tochemistry consistently revealed increased numbers of
cells secreting Th2 cytokines in the lungs of mice particu-
larly, IL-4, IL-5, and IL-13. All these features are significant
biomarkers detected in allergic subjects and particularly in
latex allergy [30]. One of the more striking features was
the accumulation of large numbers of inflammatory cells
in the perivascular and peribronchiolar regions of the
lung parenchyma. The infiltrating cells included lym-
phocytes, macrophages, and occasional neutrophils with
strikingly large numbers of infiltrating eosinophils. Co-
stimulatory molecules including CD80, CD86, and
OX40L all had increased expression in latex sensitized
mice as compared to normal mice [26]. Thus, the model
has all the distinguishing features of IgE mediated allergy.
Mice exhibiting allergic responses to latex upon treatment
with curcumin showed either reduced expression of sev-
eral Th2 parameters or they remained unchanged from
normal control mice. It is interesting that no major differ-
ences were noted in the antibody levels of the latex chal-
lenged mice from those sensitized with latex and treated
with curcumin. However, total serum IgE was reduced in
the latter group of mice. A complete disappearance of
eosinophils in the lungs and a consistent reduction in the
inflammatory response as indicated by fewer inflamma-
tory loci were two of the more remarkable features in cur-
cumin-treated, latex-sensitized mice. Reduced expression
of co-stimulatory molecules on T-lymphocytes, B-lym-
phocytes, macrophages, and granulocytes was also noted.
Taken together, our data indicate that curcumin is capable
of down regulating the allergic response in mice chal-
lenged with latex allergens. Although some of the Th2
responses were only marginally reduced in curcumin-
treated, latex-sensitized mice, other Th2 parameters were
strikingly reduced. The number of IFN-γ expressing cells in
the lungs of latex treated mice also increased indicating an
admixture of both Th1 and Th2 responses in this model.
It is possible that the lung inflammation may be a result
of the IFN-γ mediated Th1 response (Fig. 4C, D, E &4F),
while the type 1hypersensitivity is the result of a Th2
cytokine and IgE response [24,31,32]. The fewer lesions
and less inflammation in the lung of curcumin-treated,
latex-sensitized mice support this contention. IFN-γ levels
in the lungs of these animals were much lower than those
detected in latex challenged and curcumin treated mice
where IFN-γ secreting cells were almost comparable to
normal control mice treated with curcumin only. This
may have profound influence in eliciting the allergic
inflammation, a switch from a Th2 cytokine profile in
acute lesions to increased IFN-γ levels and high numbers
of cytolytic T cells in chronic lesions, while type 2
cytokines still remain high. The results suggest that curcu-
min reduced the IFN-γ producing cells in the lung result-
ing in the reduced inflammation that was detected in
latex-sensitized mice. Curcumin treatment also reduced
various Th2 cytokines producing lung cells.
Ly75 (CD-205), MMP-9, and OAT were all at lower levels
in latex-sensitized mice treated with curcumin compared
to those not treated with curcumin. Curcumin treated
mice also showed reduced expression of TSLP. The
reduced TSLP may result in lower IFN-γ production,
which then results in a reduced inflammatory lung
response [24,33-35]. The reduced TSLP levels further sub-
stantiate the reduced inflammatory response induced by
curcumin. Arginase metabolism results in the production
of ornithine, which produce proline by the activity of the
enzyme OAT. Proline inhibits collagen production in the
lungs and, therefore, may be directly involved in airway
remodeling [36]. Curcumin may have a direct effect on
this process by down regulating OAT. In previous reports
by us and others, arginase has been shown to be markedly
increased in Aspergillus induced allergy [37,38]. Upregula-
tion of enzymes in arginine metabolism may also imply
an enhanced nitric oxide (NO) production[36]. MMP-9
correlates with enhanced tissue destruction in allergic air-
way disease [39], and MMP-9 was markedly increased in
latex challenged mice, but showed a reduction in curcu-
min treated latex sensitized mice. Thus, the inflammatoryClinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Histology of the lungs studied from control and experimental mice Figure 4
Histology of the lungs studied from control and experimental mice. A. Lungs of the control mice stained by Hematoxylin and 
eosin (H&E) ×40. B. Lung tissues stained with PAS ×40. C. Latex challenged mice, H&E at ×40. D. Latex challenged mice at 
×400. E. Latex challenged mice stained with PAS at ×400. F. Latex challenged mice stained with PAS at ×400. G. Lung section 
from curcumin treated mice (Group 3), H&E at ×40. H. Lung sections from curcumin treated mice but magnification H&E at 
×400. I. Lung section from curcumin treated mice stained with PAS at ×40.Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Immunohistochemical staining for IL-4, IL-5, IL-13, and IFN-γ of control mice (Group 1), latex challenged mice (Group 2), and  latex challenged treated with curcumin (Group 3) Figure 5
Immunohistochemical staining for IL-4, IL-5, IL-13, and IFN-γ of control mice (Group 1), latex challenged mice (Group 2), and 
latex challenged treated with curcumin (Group 3). A. IL-4; B. IL-5; C. IL-13; and D. IFN-γ.
markers of lung inflammation showed an overall reduc-
tion in latex sensitized and curcumin treated mice.
Previous studies have indicated that curcumin reduces
inflammation through inhibition of STAT3 phosphoryla-
tion [40]. These same findings also indicated that curcu-
min does not inhibit STAT5 or IFN-γ inducible STAT1
expression. However, curcumin has been shown to inhibit
Dermatophagoides farineae induced IL-4 and IL-5 produc-
tion similar to what we observed in the present study [15].
It has been reported that NO production by Leishmania
was decreased in curcumin treated BALB/c mice infected
with Leishmania larvae. This reduction in NO is significant
as it is a salient feature of asthma and allergy [41].Clinical and Molecular Allergy 2007, 5:1 http://www.clinicalmolecularallergy.com/content/5/1/1
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Conclusion
The results presented in this report clearly suggest that cur-
cumin, the active ingredient of turmeric, is capable of
reducing or suppressing the Th2 response induced in mice
by exposing them to latex allergens. Although the exact
mechanism is not clearly understood, it is possible that a
number of different mechanisms are concurrently at
work. This may include suppression of Th2 responses as
evidenced by reduced IL-4 and IL-13 production and
depletion of eosinophils in the lungs, and attenuation of
lung inflammation through expression of molecules such
as TSLP, MMP-9, and OAT. The results indicate that curcu-
min has potential therapeutic value in allergy. However,
further studies are needed to understand the exact mecha-
nism involved in curcumin induced suppression of aller-
gic responses.
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